Latest news
Percheron Therapeutics (ASX:PER): Why Is Clinical Progress in Focus? - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 02:26:00 GMTPercheron Advances Lead Cancer Drug Minperstobart and Raises $2.2m for New Trial - TipRanksTipRanks · Mon, 03 Aug 2026 04:08:18 GMTPercheron Therapeutics targets clinical return for HMBD-002 after productive June quarter - Proactive InvestorsProactive Investors · Fri, 31 Jul 2026 00:42:00 GMT